During the infection, subepithelial DCs present SARS-CoV-2-specific peptides through MHC class I and II molecules on the cell surface, thus promoting the activation of CD8+ and CD4+ T cells, respectively, which migrate to the lung after antigen exposure. The gene discussed is CD8A; the disease is infection.